Gene · 5105
Papers3,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The multi-tissue gene expression and physiological responses of water deprived Peromyscus eremicus. | BMC Genomics | 2024 | 39118009 | PubTator, text mining | PubMed |
| Metabolic modelling identifies mitochondrial Pi uptake and pyruvate efflux as key aspects of daytime metabolism and proton homeostasis in crassulacean acid metabolism leaves. | New Phytol | 2024 | 39113419 | PubTator, text mining | PubMed |
| [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation]. | Zhonghua Zhong Liu Za Zhi | 2024 | 39034804 | PubTator, text mining | PubMed |
| Hepatokines: unveiling the molecular and cellular mechanisms connecting hepatic tissue to insulin resistance and inflammation. | Acta Diabetol | 2024 | 39031190 | PubTator, text mining | PubMed |
| Exposure to PFAS chemicals induces sex-dependent alterations in key rate-limiting steps of lipid metabolism in liver steatosis. | Front Toxicol | 2024 | 38903859 | PubTator, text mining | PubMed |
| Gualou-Xiebai-Banxia-Tang regulates liver-gut axis to ameliorate Metabolic Syndrome in HFD-fed mice. | Phytomedicine | 2024 | 38901285 | PubTator, text mining | PubMed |
| PCK1-mediated glycogenolysis facilitates ROS clearance and chemotherapy resistance in cervical cancer stem cells. | Sci Rep | 2024 | 38871968 | PubTator, text mining | PubMed |
| Identification of subclusters and prognostic genes based on GLS-associated molecular signature in ulcerative colitis. | Sci Rep | 2024 | 38849409 | PubTator, text mining | PubMed |
| Biosynthesis of polyhydroxybutyrate from methane and carbon dioxide using type II methanotrophs. | Bioresour Technol | 2024 | 38838829 | PubTator, text mining | PubMed |
| Identification of Genes Crucial for Biological Processes in Breast Cancer Liver Metastasis Relapse. | Int J Mol Sci | 2024 | 38791477 | PubTator, text mining | PubMed |
| Phosphoenolpyruvate carboxykinase-1 targeted siRNA promotes wound healing in type 2 diabetic mice by restoring glucose homeostasis. | Int J Biol Macromol | 2024 | 38772464 | PubTator, text mining | PubMed |
| Spatial hepatocyte plasticity of gluconeogenesis during the metabolic transitions between fed, fasted and starvation states. | bioRxiv | 2024 | 38746329 | PubTator, text mining | PubMed |
| Prediction of novel biomarkers for gastric intestinal metaplasia and gastric adenocarcinoma using bioinformatics analysis. | Heliyon | 2024 | 38737262 | PubTator, text mining | PubMed |
| A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1. | Cell Metab | 2024 | 38718791 | PubTator, text mining | PubMed |
| Dysregulation of phosphoenolpyruvate carboxykinase in cancers: A comprehensive analysis. | Cell Signal | 2024 | 38697449 | PubTator, text mining | PubMed |
| Identification and functional analysis of lactic acid metabolism-related differentially expressed genes in hepatocellular carcinoma. | Front Genet | 2024 | 38689649 | PubTator, text mining | PubMed |
| Metabolic Messengers: Thyroid Hormones. | Nat Metab | 2024 | 38671149 | PubTator, text mining | PubMed |
| Expression and functional significance of phosphoenolpyruvate carboxykinase 1 in uveal melanoma. | Cell Death Discov | 2024 | 38670942 | PubTator, text mining | PubMed |
| Pathogenic Potential of a PCK1 Gene Variant in Cytosolic PEPCK Deficiency: A Compelling Case Study. | Am J Case Rep | 2024 | 38656928 | PubTator, text mining | PubMed |
| Inhibition of Pck1 in intestinal epithelial cells alleviates acute pancreatitis via modulating intestinal homeostasis. | FASEB J | 2024 | 38651689 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5105/papers?page=10